Wednesday, May 20, 2015 9:14:11 PM
combined, has been invested into CryoPort between Shelton and Rathmann.. You don't throw that type of capital around lightly.. Specifically, because one wants to improve their resume, or, face a challenge.. You invest that 7 figure sum for a return on capital.. So when the board decided to reverse the stock and raise additional equity, the two aforementioned individuals did not escape unscathed.. The big difference between us and them, Shelton & Rathmann are front row..I would suspect most of us on this board are in the cheap seats.. This alignment with the shareholders, one of the major reasons I feel very confident regarding any strategic decision that is made by upper management.. Especially, perhaps, when it's two of the largest shareholders involved in that process..
As far as the numbers are concerned.. Revenue, 20% QoQ, okay, but 30%, 35% plus would be more acceptable.. 30% gross margin, nothing wrong with that at this stage.. And if you have not read the 10k, there's a paragraph that estimates 6/7 million frozen shipments annually.. If adapted to meet additional temperatures, 55/60 million shipments annually..
Remember, Aegis has promised a guaranteed 15 million.. That's unheard for an over the counter stock..And if Aegis is making that promise, which is a major risk for Aegis. One WOULD THINK, Aegis has done their home work.. And this is another reason I remain confident moving forward..
Recent CYRX News
- Cryoport Reports Fourth Quarter and Full Year 2023 Financial Results • PR Newswire (US) • 03/12/2024 08:05:00 PM
- Cryoport to Report Fourth Quarter and Full Year 2023 Financial Results on March 12, 2024 • PR Newswire (US) • 02/27/2024 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/15/2024 09:42:22 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/14/2024 05:22:50 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/26/2024 09:23:48 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 12/21/2023 09:30:37 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 12/20/2023 05:15:04 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2023 12:19:00 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 12/15/2023 10:09:12 PM
- Form POSASR - Post-effective Amendment to an automatic shelf registration statement • Edgar (US Regulatory) • 12/15/2023 10:05:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/13/2023 11:02:05 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 12/11/2023 10:09:00 PM
- Cryoport and NIPPON EXPRESS HOLDINGS Form Global Strategic Partnership for Temperature-Controlled Supply Chain Services • PR Newswire (US) • 11/27/2023 01:30:00 PM
- Cryoport's CRYOPDP Expands U.S. Footprint with Acquisition of Bluebird Express • PR Newswire (US) • 11/16/2023 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/15/2023 09:30:42 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 07:18:41 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/08/2023 09:31:41 PM
- Cryoport Reports Third Quarter 2023 Financial Results • PR Newswire (US) • 11/08/2023 09:05:00 PM
- Cryoport Continues its Expansion in the European Market with Tec4med Lifescience GmbH Acquisition • PR Newswire (US) • 11/02/2023 12:30:00 PM
- Cryoport to Report Third Quarter 2023 Financial Results on November 8, 2023 • PR Newswire (US) • 10/25/2023 12:30:00 PM
- Cryoport Inks New Multi-Year Supply Chain Solutions Agreement with Monash IVF • PR Newswire (US) • 10/12/2023 12:30:00 PM
- Cryoport and Cell and Gene Therapy Catapult Announce Strategic Collaboration at Stevenage Manufacturing Innovation Centre for Advancement of Cell and Gene Therapies • PR Newswire (US) • 10/10/2023 12:30:00 PM
- Be The Match BioTherapies® and Cryoport Partner to Accelerate the Development of Cell and Gene Therapies • PR Newswire (US) • 10/09/2023 08:05:00 PM
- Cryoport Receives 2023 IMAPAC Asia Pacific Cell & Gene Therapy Excellence Award • PR Newswire (US) • 09/14/2023 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/13/2023 09:01:37 PM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • BLO • Apr 25, 2024 8:52 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM